Variants in TP73 are associated with risk for amyotrophic lateral sclerosis (ALS), according to a study published online.
Apitegromab is a selective inhibitor of the inactive form of myostatin to block its activation in the muscle.
A team of investigators from McMaster University assessed the effect of aging on skeletal muscle function in individuals with and without type 1 diabetes.
A team of investigators evaluated the relationship between changes in AChR Ab levels induced by immunosuppressive treatment and myasthenia gravis prognosis at 1-year following treatment in patients with the disease.
Efgartigimod may be an effective and well-tolerated treatment option for patients with myasthenia gravis.
During the AAN 2021 Virtual Annual Meeting, investigators presented their findings on the safety and efficacy of onasemnogene abeparvovec (formerly AVXS-101) in presymptomatic SMA patients with 3 copies of the survival motor neuron 2 gene.
Investigators evaluated the characteristics and risk factors for neurologic adverse events associated with immune checkpoint inhibitors.
Investigators assessed the safety and efficacy of tacrolimus monotherapy as an initial approach for patients with drug-naïve myasthenia gravis.
In this retrospective review, study researchers sought to assess the presentation of movement disorders in carriers of C9orf72 hexanucleotide repeat expansions.
The transition from the International Classification of Disease (ICD)-9 to ICD-10 coding system may impact estimates of neurologic disease prevalence.